Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 3.860E-08 | 1.201E-04 | CA12, CA13, CA7, CA9 |
BP | GO:0009987; cellular process | GO:0001973; adenosine receptor signaling pathway | 6.752E-08 | 1.634E-04 | ADORA1, ADORA2A, ADORA3 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 8.851E-08 | 1.927E-04 | CA12, CA13, CA7, CA9 |
BP | GO:0051179; localization | GO:0015860; purine nucleoside transmembrane transport | 9.167E-07 | 1.174E-03 | SLC28A2, SLC28A3 |
BP | GO:0051179; localization | GO:1904823; purine nucleobase transmembrane transport | 2.748E-06 | 2.217E-03 | SLC28A1, SLC28A3 |
BP | GO:0051179; localization | GO:0015855; pyrimidine nucleobase transport | 2.748E-06 | 2.217E-03 | SLC28A1, SLC28A3 |
BP | GO:0009987; cellular process | GO:0038183; bile acid signaling pathway | 2.748E-06 | 2.217E-03 | GPBAR1, NR1H4 |
CC | GO:0044464; cell part | GO:0099056; integral component of presynaptic membrane | 2.748E-06 | 2.217E-03 | ADORA1, ADORA2A |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 9.062E-10 | 9.866E-06 | CA12, CA13, CA7, CA9 |
MF | GO:0060089; molecular transducer activity | GO:0001609; G-protein coupled adenosine receptor activity | 2.817E-08 | 1.022E-04 | ADORA1, ADORA2A, ADORA3 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00240 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 4.404E-03 | 2.863E-02 | CDA; TK1 |
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.373E-09 | 3.571E-08 | CA12; CA7; CA9; CA13 |
hsa00983 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 8.632E-04 | 1.122E-02 | CDA; TK1 |
hsa03013 | RNA transport_Homo sapiens_hsa03013 | 1.142E-02 | 4.243E-02 | SMN2; SMN1 |
hsa04022 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.080E-02 | 4.243E-02 | ADORA3; ADORA1 |
hsa04024 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.507E-02 | 4.898E-02 | ADORA2A; ADORA1 |
hsa04071 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 5.711E-03 | 2.970E-02 | ADORA3; ADORA1 |
hsa04080 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.161E-03 | 1.873E-02 | ADORA2A; ADORA3; ADORA1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | ADORA3 |
A00-B99: Certain infectious and parasitic diseases | Sepsis | A40, A41 | ADORA1 |
A00-B99: Certain infectious and parasitic diseases | Adult varicella zoster virus infection | B02 | TK1 |
C00-D49: Neoplasms | Cancer | C00-C96 | CA9; ADORA3; TK1 |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; CDA; TK1 |
C00-D49: Neoplasms | Breast cancer | C50 | CA9 |
C00-D49: Neoplasms | Hepatocellular carcinoma | C22.0 | ADORA3 |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9 |
C00-D49: Neoplasms | Pancreatic cancer | C25 | TK1 |
C00-D49: Neoplasms | Renal cancer | C64 | CA9 |